The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Detection of early-stage pancreatic ductal adenocarcinoma (PDAC): Sensitivity, specificity, and discriminatory properties of the serum-based PAM4-immunoassay.
David V. Gold
No relevant relationships to disclose
Jochen Gaedcke
No relevant relationships to disclose
B. Michael Ghadimi
No relevant relationships to disclose
Michael Goggins
No relevant relationships to disclose
Ralph H. Hruban
No relevant relationships to disclose
Mengling Liu
No relevant relationships to disclose
Guy Newsome
No relevant relationships to disclose
David M. Goldenberg
Employment or Leadership Position - Immunomedics
Stock Ownership - Immunomedics